John Z. Liang

450 total citations
16 papers, 353 citations indexed

About

John Z. Liang is a scholar working on Epidemiology, Microbiology and Family Practice. According to data from OpenAlex, John Z. Liang has authored 16 papers receiving a total of 353 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 5 papers in Microbiology and 2 papers in Family Practice. Recurrent topics in John Z. Liang's work include Pneumonia and Respiratory Infections (9 papers), Respiratory viral infections research (5 papers) and Pneumocystis jirovecii pneumonia detection and treatment (5 papers). John Z. Liang is often cited by papers focused on Pneumonia and Respiratory Infections (9 papers), Respiratory viral infections research (5 papers) and Pneumocystis jirovecii pneumonia detection and treatment (5 papers). John Z. Liang collaborates with scholars based in United States, China and United Kingdom. John Z. Liang's co-authors include William H. Lyness, J J Shelmet, Sherwyn Schwartz, William C. Gruber, Daniel A. Scott, David Hassman, Richard E. Sievers, Richard L. Weinstein, Emilio A. Emini and S. Tansey and has published in prestigious journals such as Vaccine, Thrombosis and Haemostasis and The Pediatric Infectious Disease Journal.

In The Last Decade

John Z. Liang

16 papers receiving 337 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Z. Liang United States 9 164 104 83 41 32 16 353
Sílvio OM Prietsch Brazil 9 139 0.8× 16 0.2× 122 1.5× 12 0.3× 3 0.1× 10 483
Subhashini A. Sellers United States 6 237 1.4× 6 0.1× 17 0.2× 41 1.0× 6 0.2× 11 404
Sedat Kadanalı Türkiye 15 58 0.4× 32 0.3× 19 0.2× 2 0.0× 11 0.3× 39 503
Miwa Haranaka Japan 9 101 0.6× 4 0.0× 21 0.3× 21 0.5× 2 0.1× 26 261
Akiko Mizukami Japan 11 152 0.9× 6 0.1× 13 0.2× 8 0.2× 7 0.2× 22 283
Pavani Garlapati United States 10 117 0.7× 6 0.1× 9 0.1× 57 1.4× 8 0.3× 34 307
Vinícius Lins Ferreira Brazil 14 151 0.9× 70 0.7× 4 0.0× 16 0.4× 1 0.0× 34 368
P. Wantzin Denmark 13 513 3.1× 30 0.3× 5 0.1× 5 0.1× 14 0.4× 26 671
Livia Piccioni Italy 9 134 0.8× 12 0.1× 8 0.1× 5 0.1× 9 0.3× 15 197
Anja Potthoff Germany 10 72 0.4× 9 0.1× 6 0.1× 8 0.2× 150 4.7× 24 249

Countries citing papers authored by John Z. Liang

Since Specialization
Citations

This map shows the geographic impact of John Z. Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Z. Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Z. Liang more than expected).

Fields of papers citing papers by John Z. Liang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Z. Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Z. Liang. The network helps show where John Z. Liang may publish in the future.

Co-authorship network of co-authors of John Z. Liang

This figure shows the co-authorship network connecting the top 25 collaborators of John Z. Liang. A scholar is included among the top collaborators of John Z. Liang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Z. Liang. John Z. Liang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Pittman, Debra D., Holly Soares, John McKay, et al.. (2024). Field Study and Correlative Studies of Factor IX Variant FIX-R338L in Participants Treated with Fidanacogene Elaparvovec. Thrombosis and Haemostasis. 124(10). 912–921. 5 indexed citations
2.
Frenck, Robert W., John Z. Liang, Kathrin U. Jansen, et al.. (2023). A Longitudinal Study of Group A Streptococcal Colonization and Pharyngitis in US Children. The Pediatric Infectious Disease Journal. 42(12). 1045–1050. 6 indexed citations
3.
Zhu, Fengcai, Yuemei Hu, Jingxin Li, et al.. (2019). Immunogenicity and Safety of the 13-Valent Pneumococcal Conjugate Vaccine Administered in a 3 + 1 versus 2 + 1 Dose Schedule Among Infants in China. The Pediatric Infectious Disease Journal. 38(11). 1150–1158. 6 indexed citations
4.
5.
Zhu, Fengcai, Yuemei Hu, Jingxin Li, et al.. (2016). Immunogenicity and Safety of 13-valent Pneumococcal Conjugate Vaccine Compared With 7-valent Pneumococcal Conjugate Vaccine Among Healthy Infants in China. The Pediatric Infectious Disease Journal. 35(9). 999–1010. 8 indexed citations
6.
7.
8.
Zhu, Fengcai, Yuemei Hu, Qi Liang, et al.. (2015). Safety and tolerability of 13-valent pneumococcal conjugate vaccine in healthy Chinese adults, children and infants. Therapeutic Advances in Drug Safety. 6(6). 206–211. 2 indexed citations
9.
Liang, John Z., et al.. (2013). P.45: The Study of LCD Module Assembly Mura. SID Symposium Digest of Technical Papers. 44(1). 1163–1166. 2 indexed citations
10.
Díez‐Domingo, Javier, Alejandra Gurtman, Francisco Giménez‐Sánchez, et al.. (2013). Evaluation of 13-valent pneumococcal conjugate vaccine and concomitant meningococcal group C conjugate vaccine in healthy infants and toddlers in Spain. Vaccine. 31(46). 5486–5494. 11 indexed citations
11.
12.
13.
Berry, Scott, Gary S. Littman, John Z. Liang, et al.. (2010). A Bayesian dose-finding trial with adaptive dose expansion to flexibly assess efficacy and safety of an investigational drug. Clinical Trials. 7(2). 121–135. 30 indexed citations
14.
15.
Bode, Bruce W., J J Shelmet, David Hassman, et al.. (2004). Patient Perception and Use of an Insulin Injector/Glucose Monitor Combined Device. The Diabetes Educator. 30(2). 301–308. 8 indexed citations
16.
Shelmet, J J, Sherwyn Schwartz, Gregory M. Peterson, et al.. (2003). Preference and resource utilization in elderly patients: InnoLet® versus vial/syringe. Diabetes Research and Clinical Practice. 63(1). 27–35. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sílvio OM Prietsch Breakdown of academic impact, for papers by Subhashini A. Sellers Breakdown of academic impact, for papers by Sedat Kadanalı Breakdown of academic impact, for papers by Miwa Haranaka Breakdown of academic impact, for papers by Akiko Mizukami Breakdown of academic impact, for papers by Pavani Garlapati Breakdown of academic impact, for papers by Vinícius Lins Ferreira Breakdown of academic impact, for papers by P. Wantzin Breakdown of academic impact, for papers by Livia Piccioni Breakdown of academic impact, for papers by Anja Potthoff
Rankless by CCL
2026